文献速递乳腺癌放疗

缩短部分乳腺照射疗程对经济毒性的影响:随机临床试验

Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-06-15

在一项纳入778例早期乳腺癌保乳术后患者的3期随机试验中,比较15-22次与5次部分乳腺照射的经济毒性。结果显示,实验组从基线至放疗结束的经济毒性评分改善-2.0(95%CI -3.6至-0.4;

要点

  • 缩短放疗疗程平均15天可小幅降低放疗结束时经济毒性。
  • 经济毒性评分改善幅度(-2.0)低于最小重要差异(2.2)。
  • 52个经济毒性条目中9个在放疗结束时支持实验组,无条目支持对照组。

核心结论

  • 对于适合部分乳腺照射的早期乳腺癌患者,缩短放疗时长平均15天可降低放疗结束时的经济毒性,但改善幅度小于本研究估计的最小重要差异。

研究设计与样本

  • 3期随机对照试验纳入778例≥40岁、因早期乳腺癌行区段乳房切除术的患者,来自12个美国癌症中心,1:1随机分为对照组长疗程部分乳腺照射385例与实验组短疗程393例(NCT03077841)。

主要发现

  • 经济毒性评分的最小重要差异估计为2.2(95%CI 1.0-3.4)。

关键数值与推荐

  • 经济毒性采用经济压力与韧性量表评分,范围0-100,评分越高表示经济毒性越差。
  • 分析基于基线及放疗结束评估,完成率96.1%(n=1496/1556)。
  • 最小重要差异以患者报告的总体财务状况变化为锚定估计。

临床怎么用

  • 在向适合部分乳腺照射的早期乳腺癌患者沟通缩短疗程时,可提及经济毒性有小幅改善但可能低于临床重要阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Within a randomized clinical trial comparing partial breast irradiation (PBI) dosing schedules, we sought to determine whether shortening the radiation course would reduce financial toxicity (FT). METHODS AND MATERIALS: In a phase 3 trial of 778 women aged ≥40 years who underwent segmental mastectomy for early breast cancer at 12 US cancer centers, patients were randomized 1:1 to external beam PBI using 15-22 fractions (control, n = 385) versus 513 fractions (experimental, n = 393) (NCT03077841). FT was assessed using comprehensive, multi-item instruments and scored using the Economic Strain and Resilience in Cancer measure at baseline, end of radiation treatment (EoT), and 6- and 18-months after radiation on a scale of 0-100 (higher score indicated worse FT). Mixed linear multivariable regression estimated adjusted difference-in-differences between EoT versus baseline FT by treatment arm. Minimal important difference (MID) in Economic Strain and Resilience in Cancer score from baseline to EoT was estimated, anchored on change in patient-reported overall financial situation during that interval. RESULTS: Treatment arms had balanced clinical and sociodemographic characteristics. Median PBI duration was 22 days (IQR, 21-25) for the control arm versus 7 days (IQR, 5-10) for the experimental arm (P < .001). FT measures were completed for 96.1% of baseline and EoT assessments (n = 1496/1556). Adjusted improvement in FT score between baseline to EoT was -2.0 (95% CI, -3.6 to -0.4; P = .02) for the experimental versus control arm. Of 52 individual FT items assessed, 9 favored the experimental arm at EoT (P < .05), whereas none favored the control arm. MID in Economic Strain and Resilience in Cancer score was 2.2 (95% CI, 1.0-3.4). CONCLUSIONS: For patients with early breast cancer eligible for PBI, shortening the radiation duration by an average of 15 days yielded a reduction in end of treatment FT that was less than the MID estimated in this study.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Smith GL, Wu CF, Joyner M, et al. Financial Toxicity of Shorter Versus Longer Partial Breast Irradiation: A Randomized Clinical Trial. Int J Radiat Oncol Biol Phys. 2026. PMID: 42297155. doi:10.1016/j.ijrobp.2026.05.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。